Global Pompe Disease Treatment market [2016-2030] Americas by Therapy

Growth Outlook

• The 2030] Americas by Therapy portion of the Global Pompe Disease Treatment market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 568 Mn in 2026 and is projected to reach USD 652 Mn by 2030 — a gain of about 15% over the forecast period, translating to a CAGR in the mid-single digits.
• enzyme replacement therapy ert segment accounted for the largest market share in 2018, this market is expected to reach USD 457. 70 Million in 2030 from USD 323.
• What the regional split looks like (2026): Enzyme Replacement Therapy (ERT) leads, holding roughly 70% of segment value — the single largest regional share. Gene Therapy is the second-largest contributor. Others make up the remainder, in descending order.
• By 2030, Enzyme Replacement Therapy (ERT) alone is expected to reach USD 458 Mn, with Gene Therapy at USD 138 Mn.

Market Dynamics

enzyme replacement therapy ert segment accounted for the largest market share in 2018, this market is expected to reach USD 457.70 Million in 2030 from USD 323.30 Million in 2018. This market is projected to grow at a CAGR of 3.00% during the forecast period from 2019 - 2030. However, gene therapy segment is the fastest growing market, which is expected to grow at a CAGR of 3.26% during the forecast period 2019 - 2030.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.